E Fund Management Co. Ltd. Invests $809,000 in CVS Health Corporation $CVS

E Fund Management Co. Ltd. bought a new position in shares of CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 7,825 shares of the pharmacy operator’s stock, valued at approximately $809,000.

A number of other institutional investors have also made changes to their positions in the business. Westport Asset Management Inc. bought a new stake in CVS Health during the 2nd quarter worth about $1,839,000. Asahi Life Asset Management CO. LTD. acquired a new position in shares of CVS Health during the second quarter worth approximately $582,000. Somerville Kurt F bought a new stake in shares of CVS Health during the second quarter valued at approximately $248,000. Frazier Financial Advisors LLC acquired a new position in CVS Health during the 2nd quarter worth $144,000. Finally, Edmond DE Rothschild Holding S.A. acquired a new stake in shares of CVS Health in the 2nd quarter valued at $29,865,000. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Down 1.4%

Shares of NYSE:CVS opened at $93.58 on Thursday. The company has a 50 day moving average price of $102.32 and a two-hundred day moving average price of $88.69. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The company has a market capitalization of $119.68 billion, a PE ratio of 24.76, a PEG ratio of 0.91 and a beta of 0.61. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. During the same quarter in the previous year, the business posted $1.81 EPS. CVS Health’s revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. CVS Health’s dividend payout ratio (DPR) is 70.37%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on CVS shares. TD Cowen raised their price target on CVS Health from $105.00 to $110.00 and gave the company a “buy” rating in a report on Monday, May 11th. Deutsche Bank Aktiengesellschaft raised their target price on shares of CVS Health from $88.00 to $92.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Mizuho lifted their price target on shares of CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Sanford C. Bernstein increased their price objective on shares of CVS Health from $94.00 to $106.00 and gave the company an “outperform” rating in a report on Tuesday, May 12th. Finally, JPMorgan Chase & Co. raised their price objective on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Twenty-two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $107.17.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.